Log in to save to my catalogue

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain micro...

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain micro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67593636

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorder

About this item

Full title

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorder

Publisher

Berlin: Springer

Journal title

Psychopharmacologia, 2006-01, Vol.184 (1), p.122-129

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Scope and Contents

Contents

Several drugs used to treat bipolar disorder (lithium and carbamazepine), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective phospholipase A(2). Although chronic valproic acid produces similar effects on brai...

Alternative Titles

Full title

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorder

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67593636

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67593636

Other Identifiers

ISSN

0033-3158

E-ISSN

1432-2072

DOI

10.1007/s00213-005-0272-4

How to access this item